Related Experiment Video
Updated: May 10, 2025

An Affordable HIV-1 Drug Resistance Monitoring Method for Resource Limited Settings
Published on: March 30, 2014
Not Getting to Zero HIV Infections Among People Who Inject Drugs in San Francisco, California
Moranda Tate1, Bow Suprasert1, Danyion Reagan1
1Center for Public Health Research, San Francisco Department of Public Health, San Francisco, CA, USA.
None:
We analyzed data from San Francisco's National HIV Behavioral Surveillance for 2018 and 2022 to assess progress towards getting to zero HIV infections among people who inject drugs (PWID). HIV prevalence showed little change from 2018 (10.9%) to 2022 (11.4%). UNAIDS 90-90-90 targets were not met during the four-year interval, accompanied by a drop in HIV testing in the last year (from 73.5 to 43.4%, X2(1) = 82.76, p < 0.001). We found no evidence that the HIV epidemic is heading towards zero among PWID. Our data are a wakeup call to revitalize our HIV epidemic response, especially for marginalized populations.
More Related Videos
23:56Comprehensive & Cost Effective Laboratory Monitoring of HIV/AIDS: an African Role Model
Published on: October 31, 2010
13:58Amplifying and Quantifying HIV-1 RNA in HIV Infected Individuals with Viral Loads Below the Limit of Detection by Standard Clinical Assays
Published on: September 26, 2011
Related Concept Videos
Sexually Transmitted Infections
Retrovirus Life Cycles
Pulmonary Tuberculosis I
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
Healthcare Associated Infections II: Preventive Measures
The best practices for preventing healthcare-associated infections include hand hygiene, patient risk...
Immunodeficiency Diseases
There are three main causes of immunodeficiency...